Caseware UK (AP4) 2024.0.164 2024.0.164 2024-11-302024-11-302023-12-01falseGastroenterology consultancy2true2trueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 12335236 2023-12-01 2024-11-30 12335236 2022-12-01 2023-11-30 12335236 2024-11-30 12335236 2023-11-30 12335236 c:Director1 2023-12-01 2024-11-30 12335236 c:Director2 2023-12-01 2024-11-30 12335236 c:RegisteredOffice 2023-12-01 2024-11-30 12335236 d:OfficeEquipment 2023-12-01 2024-11-30 12335236 d:OfficeEquipment 2024-11-30 12335236 d:OfficeEquipment 2023-11-30 12335236 d:OfficeEquipment d:OwnedOrFreeholdAssets 2023-12-01 2024-11-30 12335236 d:CurrentFinancialInstruments 2024-11-30 12335236 d:CurrentFinancialInstruments 2023-11-30 12335236 d:CurrentFinancialInstruments d:WithinOneYear 2024-11-30 12335236 d:CurrentFinancialInstruments d:WithinOneYear 2023-11-30 12335236 d:ShareCapital 2024-11-30 12335236 d:ShareCapital 2023-11-30 12335236 d:RetainedEarningsAccumulatedLosses 2024-11-30 12335236 d:RetainedEarningsAccumulatedLosses 2023-11-30 12335236 c:OrdinaryShareClass1 2023-12-01 2024-11-30 12335236 c:OrdinaryShareClass1 2024-11-30 12335236 c:OrdinaryShareClass2 2023-12-01 2024-11-30 12335236 c:OrdinaryShareClass2 2024-11-30 12335236 c:OrdinaryShareClass3 2023-12-01 2024-11-30 12335236 c:OrdinaryShareClass3 2024-11-30 12335236 c:FRS102 2023-12-01 2024-11-30 12335236 c:AuditExemptWithAccountantsReport 2023-12-01 2024-11-30 12335236 c:FullAccounts 2023-12-01 2024-11-30 12335236 c:PrivateLimitedCompanyLtd 2023-12-01 2024-11-30 12335236 d:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl 2023-12-01 2024-11-30 12335236 e:PoundSterling 2023-12-01 2024-11-30 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 12335236









EAST ANGLIA HEPATOBILIARY HEALTHCARE LIMITED







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 30 NOVEMBER 2024

 
EAST ANGLIA HEPATOBILIARY HEALTHCARE LIMITED
 
 
COMPANY INFORMATION


Directors
Dr S M Rushbrook 
M C L Rushbrook 




Registered number
12335236



Registered office
7 The Close

Norwich

Norfolk

NR1 4DJ




Accountants
MA Partners LLP
Chartered Accountants

7 The Close

Norwich

Norfolk

NR1 4DJ





 
EAST ANGLIA HEPATOBILIARY HEALTHCARE LIMITED
 

CONTENTS



Page
Accountants' report
 
 
1
Balance sheet
 
 
2 - 3
Notes to the financial statements
 
 
4 - 7


 
EAST ANGLIA HEPATOBILIARY HEALTHCARE LIMITED
 
 
  
CHARTERED ACCOUNTANTS' REPORT TO THE BOARD OF DIRECTORS ON THE PREPARATION OF THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF EAST ANGLIA HEPATOBILIARY HEALTHCARE LIMITED
FOR THE YEAR ENDED 30 NOVEMBER 2024

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of East Anglia Hepatobiliary Healthcare Limited for the year ended 30 November 2024 which comprise  the Balance sheet and the related notes from the Company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW)we are subject to its ethical and other professional requirements which are detailed at https://www.icaew.com /regulation.

This report is made solely to the Board of directors of East Anglia Hepatobiliary Healthcare Limited, as a body, in accordance with the terms of our engagement letter dated 24 August 2022Our work has been undertaken solely to prepare for your approval the financial statements of East Anglia Hepatobiliary Healthcare Limited and state those matters that we have agreed to state to the Board of directors of East Anglia Hepatobiliary Healthcare Limited, as a body, in this report in accordance with ICAEW Technical Release TECH07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than East Anglia Hepatobiliary Healthcare Limited and its Board of directors, as a body, for our work or for this report. 

It is your duty to ensure that East Anglia Hepatobiliary Healthcare Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and loss of East Anglia Hepatobiliary Healthcare Limited. You consider that East Anglia Hepatobiliary Healthcare Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or review of the financial statements of East Anglia Hepatobiliary Healthcare Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

  





MA Partners LLP
 
Chartered Accountants
  
7 The Close
Norwich
Norfolk
NR1 4DJ

1 April 2025
Page 1

 
EAST ANGLIA HEPATOBILIARY HEALTHCARE LIMITED
REGISTERED NUMBER: 12335236

BALANCE SHEET
AS AT 30 NOVEMBER 2024

2024
2023
Note
£
£

Fixed assets
  

Tangible assets
 4 
393
524

  
393
524

Current assets
  

Cash at bank and in hand
  
27,562
46,077

  
27,562
46,077

Creditors: amounts falling due within one year
 5 
(3,141)
(2,866)

Net current assets
  
 
 
24,421
 
 
43,211

Total assets less current liabilities
  
24,814
43,735

Provisions for liabilities
  
(98)
(100)

Net assets
  
24,716
43,635


Capital and reserves
  

Called up share capital 
 6 
30
30

Profit and loss account
  
24,686
43,605

  
24,716
43,635


Page 2

 
EAST ANGLIA HEPATOBILIARY HEALTHCARE LIMITED
REGISTERED NUMBER: 12335236
    
BALANCE SHEET (CONTINUED)
AS AT 30 NOVEMBER 2024

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 1 April 2025.






Dr S M Rushbrook
Director

The notes on pages 4 to 7 form part of these financial statements.

Page 3

 
EAST ANGLIA HEPATOBILIARY HEALTHCARE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2024

1.


General information

The Company is a private company limited by shares. It is both incorporated and domiciled in Englandand Wales. The address of its registered office is 7 The Close, Norwich, NR1 4DJ.
The Company's principal activity is that of gastroenterology services and the Company's principal place of activity is Norwich.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. 
Deferred tax balances are recognised in respect of timing differences that have originated but not reversed by the balance sheet date. 
The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income. 

 
2.3

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Office equipment
-
25%
straight line

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

Page 4

 
EAST ANGLIA HEPATOBILIARY HEALTHCARE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2024

2.Accounting policies (continued)

 
2.4

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.5

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.6

Financial instruments


The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares. 

 
2.7

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.


3.


Employees

The average monthly number of employees, including directors, during the year was 2 (2023 - 2).

Page 5

 
EAST ANGLIA HEPATOBILIARY HEALTHCARE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2024

4.


Tangible fixed assets





Office equipment

£



Cost or valuation


At 1 December 2023
699



At 30 November 2024

699



Depreciation


At 1 December 2023
175


Charge for the year on owned assets
131



At 30 November 2024

306



Net book value



At 30 November 2024
393



At 30 November 2023
524


5.


Creditors: Amounts falling due within one year

2024
2023
£
£

Other creditors
1,318
1,150

Accruals and deferred income
1,823
1,716

3,141
2,866


Page 6

 
EAST ANGLIA HEPATOBILIARY HEALTHCARE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2024

6.


Share capital

2024
2023
£
£
Allotted, called up and fully paid



10 A Ordinary shares of £1.00 each
10
10
10 B Ordinary shares of £1.00 each
10
10
10 C Ordinary shares of £1.00 each
10
10

30

30



7.


Related party transactions

As at 30 November 2024, the balance owed to the directors was £1,318 (2023: £1,150).

 
Page 7